Artigos de revistas sobre o tema "P53, 14-3-3"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "P53, 14-3-3".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Mühlmann, Gilbert, Dietmar Öfner, Matthias Zitt, Hannes M. Müller, Hans Maier, Patrizia Moser, Kurt W. Schmid, Marion Zitt e Albert Amberger. "14-3-3 Sigma And p53 Expression in Gastric Cancer and Its Clinical Applications". Disease Markers 29, n.º 1 (2010): 21–29. http://dx.doi.org/10.1155/2010/470314.
Texto completo da fonteYang, Heng-Yin, Yu-Ye Wen, Chih-Hsin Chen, Guillermina Lozano e Mong-Hong Lee. "14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth". Molecular and Cellular Biology 23, n.º 20 (15 de outubro de 2003): 7096–107. http://dx.doi.org/10.1128/mcb.23.20.7096-7107.2003.
Texto completo da fonteCHEN, DE-YU, DONG-FANG DAI, YE HUA e WEN-QING QI. "p53 suppresses 14-3-3γ by stimulating proteasome-mediated 14-3-3γ protein degradation". International Journal of Oncology 46, n.º 2 (7 de novembro de 2014): 818–24. http://dx.doi.org/10.3892/ijo.2014.2740.
Texto completo da fonteDoveston, Richard G., Ave Kuusk, Sebastian A. Andrei, Seppe Leysen, Qing Cao, Maria P. Castaldi, Adam Hendricks et al. "Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction". FEBS Letters 591, n.º 16 (agosto de 2017): 2449–57. http://dx.doi.org/10.1002/1873-3468.12723.
Texto completo da fonteRawlinson, Imogen, Carol McMenemy e David Greenhalgh. "P19 Inducible 14-3-3 sigma/stratifin ablation accelerates malignant progression in HK1.ras/fos-Δ5PTENflx transgenic mouse skin carcinogenesis". British Journal of Dermatology 189, n.º 1 (julho de 2023): e21-e21. http://dx.doi.org/10.1093/bjd/ljad174.040.
Texto completo da fonteYang, Wensheng, David T. Dicker, Jiandong Chen e Wafik S. El-Deiry. "CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2". Cell Cycle 7, n.º 5 (março de 2008): 670–82. http://dx.doi.org/10.4161/cc.7.5.5701.
Texto completo da fonteRajagopalan, Sridharan, Robert S. Sade, Fiona M. Townsley e Alan R. Fersht. "Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms". Nucleic Acids Research 38, n.º 3 (20 de novembro de 2009): 893–906. http://dx.doi.org/10.1093/nar/gkp1041.
Texto completo da fonteSchumacher, Benjamin, Justine Mondry, Philipp Thiel, Michael Weyand e Christian Ottmann. "Structure of the p53 C-terminus bound to 14-3-3: Implications for stabilization of the p53 tetramer". FEBS Letters 584, n.º 8 (3 de março de 2010): 1443–48. http://dx.doi.org/10.1016/j.febslet.2010.02.065.
Texto completo da fonteWaterman, Matthew J. F., Elena S. Stavridi, Jennifer L. F. Waterman e Thanos D. Halazonetis. "ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins". Nature Genetics 19, n.º 2 (junho de 1998): 175–78. http://dx.doi.org/10.1038/542.
Texto completo da fonteMontano, Ximena. "Common amino acid sequence motifs in p53, 14-3-3 and Akt protein families". FEBS Letters 507, n.º 2 (18 de outubro de 2001): 237–40. http://dx.doi.org/10.1016/s0014-5793(01)02903-9.
Texto completo da fonteLee, Mong-Hong, e Guillermina Lozano. "Regulation of the p53-MDM2 pathway by 14-3-3 σ and other proteins". Seminars in Cancer Biology 16, n.º 3 (junho de 2006): 225–34. http://dx.doi.org/10.1016/j.semcancer.2006.03.009.
Texto completo da fonteHardman-Carter, Rebecca, Revvekka Lefkati, Carol McMenemy e David Greenhalgh. "P10 Inducible 14-3-3 sigma/stratifin ablation cooperates with rasHa activation to accelerate papillomatogenesis and induce malignant conversion in transgenic mouse skin carcinogenesis". British Journal of Dermatology 189, n.º 1 (julho de 2023): e17-e18. http://dx.doi.org/10.1093/bjd/ljad174.032.
Texto completo da fonteAktary, Z., S. Kulak, J. Mackey, N. Jahroudi e M. Pasdar. "Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3". Journal of Cell Science 126, n.º 14 (17 de maio de 2013): 3031–42. http://dx.doi.org/10.1242/jcs.120642.
Texto completo da fonteRajagopalan, S., A. M. Jaulent, M. Wells, D. B. Veprintsev e A. R. Fersht. "14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers". Nucleic Acids Research 36, n.º 18 (6 de setembro de 2008): 5983–91. http://dx.doi.org/10.1093/nar/gkn598.
Texto completo da fonteJin, Yun-Hye, Yeon-Jin Kim, Dae-Won Kim, Kwang-Hyun Baek, Bok Yun Kang, Chang-Yeol Yeo e Kwang-Youl Lee. "Sirt2 interacts with 14-3-3 β/γ and down-regulates the activity of p53". Biochemical and Biophysical Research Communications 368, n.º 3 (abril de 2008): 690–95. http://dx.doi.org/10.1016/j.bbrc.2008.01.114.
Texto completo da fonteOkamoto, Koji, Kenji Kashima, Yaron Pereg, Michiko Ishida, Satomi Yamazaki, Ayumi Nota, Amina Teunisse et al. "DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation". Molecular and Cellular Biology 25, n.º 21 (1 de novembro de 2005): 9608–20. http://dx.doi.org/10.1128/mcb.25.21.9608-9620.2005.
Texto completo da fonteChan, Timothy A., Paul M. Hwang, Heiko Hermeking, Kenneth W. Kinzler e Bert Vogelstein. "Cooperative effects of genes controlling the G2/M checkpoint". Genes & Development 14, n.º 13 (1 de julho de 2000): 1584–88. http://dx.doi.org/10.1101/gad.14.13.1584.
Texto completo da fonteMuñoz-Fontela, Cesar, Laura Marcos-Villar, Pedro Gallego, Javier Arroyo, Marco Da Costa, Karen M. Pomeranz, Eric W. F. Lam e Carmen Rivas. "Latent Protein LANA2 from Kaposi's Sarcoma-Associated Herpesvirus Interacts with 14-3-3 Proteins and Inhibits FOXO3a Transcription Factor". Journal of Virology 81, n.º 3 (15 de novembro de 2006): 1511–16. http://dx.doi.org/10.1128/jvi.01816-06.
Texto completo da fonteKuusk, Ave, Helen Boyd, Hongming Chen e Christian Ottmann. "Small-molecule modulation of p53 protein-protein interactions". Biological Chemistry 401, n.º 8 (28 de julho de 2020): 921–31. http://dx.doi.org/10.1515/hsz-2019-0405.
Texto completo da fonteLee, Jun-Ho, e Hua Lu. "14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53". Journal of Biological Chemistry 286, n.º 7 (9 de dezembro de 2010): 5136–42. http://dx.doi.org/10.1074/jbc.m110.190470.
Texto completo da fonteYang, Huiling, Ruiying Zhao e Mong-Hong Lee. "14-3-3σ, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma". Molecular Cancer Therapeutics 5, n.º 2 (fevereiro de 2006): 253–60. http://dx.doi.org/10.1158/1535-7163.mct-05-0395.
Texto completo da fonteHermeking, Heiko, Christoph Lengauer, Kornelia Polyak, Tong-Chuan He, Lin Zhang, Sam Thiagalingam, Kenneth W. Kinzler e Bert Vogelstein. "14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression". Molecular Cell 1, n.º 1 (dezembro de 1997): 3–11. http://dx.doi.org/10.1016/s1097-2765(00)80002-7.
Texto completo da fonteLiu, Nan, Hongli Yang e Liangui Yang. "Modeling the roles of 14-3-3 σ and Wip1 in p53 dynamics and programmed cell death*". Communications in Theoretical Physics 73, n.º 8 (21 de junho de 2021): 085602. http://dx.doi.org/10.1088/1572-9494/abfd2a.
Texto completo da fonteWang, Moyu, Hongmei Li, Xiyu Sun, Jianhua Qiu, Changhua Jing, Huiyue Jia, Yujie Guo e Huijun Guo. "J Subgroup Avian Leukosis Virus Strain Promotes Cell Proliferation by Negatively Regulating 14-3-3σ Expressions in Chicken Fibroblast Cells". Viruses 15, n.º 2 (31 de janeiro de 2023): 404. http://dx.doi.org/10.3390/v15020404.
Texto completo da fonteOhtani, Shoichiro, Shunsuke Kagawa, Yasuhisa Tango, Tatsuo Umeoka, Naoyuki Tokunaga, Yousuke Tsunemitsu, Jack A. Roth, Yoichi Taya, Noriaki Tanaka e Toshiyoshi Fujiwara. "Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo". Molecular Cancer Therapeutics 3, n.º 1 (1 de janeiro de 2004): 93–100. http://dx.doi.org/10.1158/1535-7163.93.3.1.
Texto completo da fontePereg, Yaron, Suzanne Lam, Amina Teunisse, Sharon Biton, Erik Meulmeester, Leonid Mittelman, Giacomo Buscemi et al. "Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage". Molecular and Cellular Biology 26, n.º 18 (15 de setembro de 2006): 6819–31. http://dx.doi.org/10.1128/mcb.00562-06.
Texto completo da fonteOldfield, Christopher J., Jingwei Meng, Jack Y. Yang, Mary Qu Yang, Vladimir N. Uversky e A. Keith Dunker. "Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners". BMC Genomics 9, Suppl 1 (2008): S1. http://dx.doi.org/10.1186/1471-2164-9-s1-s1.
Texto completo da fonteSchumacher, Benjamin, Justine Mondry, Philipp Thiel, Michael Weyand e Christian Ottmann. "Binary complex of 14-3-3σ/p53 pT387-peptide and implications for stabilization". Acta Crystallographica Section A Foundations of Crystallography 66, a1 (29 de agosto de 2010): s148—s149. http://dx.doi.org/10.1107/s0108767310096698.
Texto completo da fonteBrownlee, Noel A., L. Allen Perkins, Will Stewart, Beth Jackle, Mark J. Pettenati, Patrick P. Koty, Samy S. Iskandar e A. Julian Garvin. "Recurring Translocation (10;17) and Deletion (14q) in Clear Cell Sarcoma of the Kidney". Archives of Pathology & Laboratory Medicine 131, n.º 3 (1 de março de 2007): 446–51. http://dx.doi.org/10.5858/2007-131-446-rtadqi.
Texto completo da fonteGu, Yanyan, Jonathan L. Kaufman, Lawrence H. Boise e Sagar Lonial. "Validation of the Function of 14-3-3 ζ in Multiple Myeloma (MM)". Blood 118, n.º 21 (18 de novembro de 2011): 1369. http://dx.doi.org/10.1182/blood.v118.21.1369.1369.
Texto completo da fonteNagappan, Arulkumar, Hyeon Soo Park, Kwang Il Park, Gyeong Eun Hong, Silvia Yumnam, Ho Jeong Lee, Mun Ki Kim et al. "Helicobacter pylori infection combined with DENA revealed altered expression of p53 and 14-3-3 isoforms in Gulo−/− mice". Chemico-Biological Interactions 206, n.º 2 (novembro de 2013): 143–52. http://dx.doi.org/10.1016/j.cbi.2013.09.002.
Texto completo da fonteBenzinger, Anne, Nemone Muster, Heike B. Koch, John R. Yates e Heiko Hermeking. "Targeted Proteomic Analysis of 14-3-3ς, a p53 Effector Commonly Silenced in Cancer". Molecular & Cellular Proteomics 4, n.º 6 (18 de março de 2005): 785–95. http://dx.doi.org/10.1074/mcp.m500021-mcp200.
Texto completo da fonteDanes, Christopher G., Shannon L. Wyszomierski, Jing Lu, Christopher L. Neal, Wentao Yang e Dihua Yu. "14-3-3ζ Down-regulates p53 in Mammary Epithelial Cells and Confers Luminal Filling". Cancer Research 68, n.º 6 (13 de março de 2008): 1760–67. http://dx.doi.org/10.1158/0008-5472.can-07-3177.
Texto completo da fonteLee, Ming Kei, e Kanaga Sabapathy. "Phosphorylation at Carboxyl-Terminal S373 and S375 Residues and 14-3-3 Binding Are Not Required for Mouse p53 Function". Neoplasia 9, n.º 9 (setembro de 2007): 690–98. http://dx.doi.org/10.1593/neo.07511.
Texto completo da fonteZhang, Bo, Bo Zhou, Guihong Huang, Jing'an Huang, Xiaoxin Lin, Zonghuai Li, Yuanchu Lian, Qiujie Huang e Yong Ye. "Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment". Heliyon 10, n.º 1 (janeiro de 2024): e24012. http://dx.doi.org/10.1016/j.heliyon.2024.e24012.
Texto completo da fonteWu, Qiao, Hua Fan, Ren Lang, Xianliang Li, Xingmao Zhang, Shaocheng Lv e Qiang He. "Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling". BioMed Research International 2020 (23 de junho de 2020): 1–9. http://dx.doi.org/10.1155/2020/3740418.
Texto completo da fonteTolcher, Anthony W., Desiree Hao, Johann de Bono, Alex Miller, Amita Patnaik, Lisa A. Hammond, Leslie Smetzer et al. "Phase I, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered Ad5CMV-p53, an Adenoviral Vector Containing the Wild-Type p53 Gene, in Patients With Advanced Cancer". Journal of Clinical Oncology 24, n.º 13 (1 de maio de 2006): 2052–58. http://dx.doi.org/10.1200/jco.2005.03.6756.
Texto completo da fonteZhang, Yiwei, Yitian Zha e Hua Lu. "Abstract 2377: Impairment of p53-activating pathways accelerates liver cancer initiation partially through MTHFD1L-mediated 1C metabolism". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 2377. http://dx.doi.org/10.1158/1538-7445.am2022-2377.
Texto completo da fonteSharma, Balkrishan, Duaa Mureb, Sumit Murab, Leah A. Rosenfeldt, Brenton J. Francisco, Alexander A. Boucher, Rachel Cantrell et al. "Fibrinogen Activates FAK to Promote the Colorectal Adenocarcinoma Growth". Blood 134, Supplement_1 (13 de novembro de 2019): 1111. http://dx.doi.org/10.1182/blood-2019-130497.
Texto completo da fonteTabe, Yoko, Yasushi Isobe, Koichi Sugimoto, Linhua Jin, Kazuo Oshimi e Takashi Miida. "The MDM2 Antagonist Nutlin-3 Is Effective to Aggressive NK-Cell Neoplasms with Wild Type p53 in Hypoxia". Blood 118, n.º 21 (18 de novembro de 2011): 4999. http://dx.doi.org/10.1182/blood.v118.21.4999.4999.
Texto completo da fonteNarasimhan, Sudha Rani, Lin Yang, Brenda I. Gerwin e V. Courtney Broaddus. "Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax". American Journal of Physiology-Lung Cellular and Molecular Physiology 275, n.º 1 (1 de julho de 1998): L165—L171. http://dx.doi.org/10.1152/ajplung.1998.275.1.l165.
Texto completo da fonteWu, Shin-Hwar, Tzu-Yun Wu, Yung-Ting Hsiao, Ju-Hwa Lin, Shu-Chun Hsu, Te-Chun Hsia, Su-Tso Yang, Wu-Huei Hsu e Jing-Gung Chung. "Bufalin Induces Cell Death in Human Lung Cancer Cells through Disruption of DNA Damage Response Pathways". American Journal of Chinese Medicine 42, n.º 03 (janeiro de 2014): 729–42. http://dx.doi.org/10.1142/s0192415x14500475.
Texto completo da fonteNunun, Somrudee, Paramee Thongsuksai, Keson Trakunrum e Pritsana Raungrut. "Down-Regulation of 14-3-3σ Reduces Proliferation of Human Lung Cancers But Not Colon Cancer Cells". Journal of Health Science and Medical Research 36, n.º 2 (24 de maio de 2018): 97. http://dx.doi.org/10.31584/jhsmr.2018.36.2.3.
Texto completo da fonteNunun, Somrudee, Paramee Thongsuksai, Keson Trakunrum e Pritsana Raungrut. "Down-Regulation of 14-3-3σ Reduces Proliferation of Human Lung Cancers But Not Colon Cancer Cells". Journal of Health Science and Medical Research 36, n.º 2 (24 de maio de 2018): 97. http://dx.doi.org/10.31584/jhsmr.v36i2.3.
Texto completo da fonteHuang, Sheng-Yen, Min-Jie Hsieh, Chu-Ying Chen, Yen-Ju Chen, Jen-Yang Chen, Mei-Ru Chen, Ching-Hwa Tsai, Su-Fang Lin e Tsuey-Ying Hsu. "Epstein–Barr virus Rta-mediated transactivation of p21 and 14-3-3σ arrests cells at the G1/S transition by reducing cyclin E/CDK2 activity". Journal of General Virology 93, n.º 1 (1 de janeiro de 2012): 139–49. http://dx.doi.org/10.1099/vir.0.034405-0.
Texto completo da fonteSzkaradkiewicz, Andrzej, Tomasz Karpiński, Jan Majewski, Kamila Malinowska, Olga Goślińska-Kuźniarek e Krzysztof Linke. "The Participation of p53 and bcl-2 Proteins in Gastric Carcinomas Associated with Helicobacter pylori and/or Epstein-Barr Virus (EBV)". Polish Journal of Microbiology 64, n.º 3 (18 de setembro de 2015): 211–16. http://dx.doi.org/10.5604/01.3001.0009.2116.
Texto completo da fonteWestfall, Matthew D., Deborah J. Mays, Joseph C. Sniezek e Jennifer A. Pietenpol. "The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations". Molecular and Cellular Biology 23, n.º 7 (1 de abril de 2003): 2264–76. http://dx.doi.org/10.1128/mcb.23.7.2264-2276.2003.
Texto completo da fonteLi, Honghui, Wenmin Cheng, Bowei Chen, Shaoxia Pu, Ninglin Fan, Xiaolin Zhang, Deling Jiao et al. "Efficient Generation of P53 Biallelic Mutations in Diannan Miniature Pigs Using RNA-Guided Base Editing". Life 11, n.º 12 (17 de dezembro de 2021): 1417. http://dx.doi.org/10.3390/life11121417.
Texto completo da fonteMartínez-Galán, Joaquina, Cynthia S. González Rivas, Julia Ruiz Vozmediano, Pedro Ballesteros, Juan Ramón Delgado, Sandra Ríos, M. Isabel Núñez, Jesus Lopez-Peñalver e Blanca Torres-Torres. "Implications prognostics of methylation 14-3-3 sigma promoter in peripheral blood cell DNA with nodal involvement status and tumor size for breast cancer patients." Journal of Clinical Oncology 30, n.º 27_suppl (20 de setembro de 2012): 33. http://dx.doi.org/10.1200/jco.2012.30.27_suppl.33.
Texto completo da fonteMaurya, Rajendra Prakash, Sanjay Kumar Bosak, Royana Singh, Virendra Pratap Singh, Samer Singh, Per O. Lundmark, Shivangi Singh, Anil Kumar e Tanmay Srivastav. "Analysis of tumor protein p53 (p53) mutations in eyelid malignancy". IP International Journal of Ocular Oncology and Oculoplasty 7, n.º 3 (15 de outubro de 2021): 243–49. http://dx.doi.org/10.18231/j.ijooo.2021.051.
Texto completo da fonte